Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

COGTCogent Biosciences, Inc.

Nasdaq · CIK 0001622229
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts304

Identity from submissions API

NameCogent Biosciences, Inc.
CIK0001622229
TickersCOGT
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN465308248
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-945-5576
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Unum Therapeutics Inc. (2017-12-04T05:00:00.000Z → 2020-10-05T04:00:00.000Z)
  • Unum Therapeutics, Inc. (2014-10-20T04:00:00.000Z → 2018-03-30T04:00:00.000Z)
Business address
180 THIRD AVENUE
4TH FLOOR
WALTHAM
MA
MA
Mailing address
180 THIRD AVENUE
4TH FLOOR
WALTHAM
MA
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

616 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-05 10-Q 10-Q 0001193125-26-449963 001-38443 261527836 34 9527627 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-449926 001-38443 261527714 34 628635 1 1
2026-10-05 4 4 0001193125-26-414218 5777
2026-09-02 8-K 8-K 1.01 0001193125-26-380194 001-38443 261354876 34 138623 1 1
2026-08-31 4 4 0001193125-26-377001 14207
2026-08-27 144 xsl144X01/primary_doc.xml 0001950047-26-008754 001-38443 261330521 33 4965
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193805-26-001082 005-90431 261273383 34 17258
2026-08-10 8-K 8-K 8.01,9.01 0001193125-26-342695 001-38443 261259577 34 155391 1 1
2026-08-10 424B5 424B5 0001193125-26-342683 333-291384 261259556 33 577993 1 1
2026-08-10 10-Q 10-Q 0001193125-26-342393 001-38443 261258522 34 8482967 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001193125-26-341315 001-38443 261256318 34 375741 1 1
2026-07-31 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001323 005-90431 261225840 34 7606
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002235 005-90431 261206128 34 11294
2026-07-06 4 4 0001193125-26-296249 5777
2026-06-11 4 4 0001193125-26-267665 6159
2026-06-11 4 4 0001193125-26-267663 5564
2026-06-11 4 4 0001193125-26-267662 6156
2026-06-11 4 4 0001193125-26-267670 5583
2026-06-11 4 4 0001193125-26-267667 5575
2026-06-11 4 4 0001193125-26-267666 5575
2026-06-11 8-K 8-K 5.07 0001193125-26-267566 001-38443 261083203 34 149510 1 1
2026-05-21 4 4 0001193125-26-234578 6495
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193805-26-000609 005-90431 26981098 34 17047
2026-05-05 10-Q 10-Q 0001193125-26-205170 001-38443 26940565 34 7420600 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001193125-26-205124 001-38443 26940535 34 345603 1 1
2026-04-23 ARS ARS 0001193125-26-173857 001-38443 26889194 34 1090316
2026-04-23 DEFA14A DEFA14A 0001193125-26-173848 001-38443 26889162 34 814007
2026-04-23 DEF 14A DEF 14A 0001193125-26-173834 001-38443 26889121 34 2654231 1 1
2026-04-03 4 4 0001193125-26-142082 5867
2026-03-31 144 xsl144X01/primary_doc.xml 0001104659-26-038058 001-38443 26824376 33 5714
2026-03-31 4 OWNERSHIP DOCUMENT 0001104659-26-038057 11018
2026-03-31 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-038056 005-90431 26824373 34 11827
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000905 005-90431 26799310 34 7374
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-26-000011 005-90431 26642707 34 15667
2026-02-17 S-8 S-8 0001193125-26-054555 333-293512 26640773 33 208559 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001907884-26-000002 005-90431 26638889 34 9523
2026-02-17 10-K 10-K 0001193125-26-053334 001-38443 26637138 34 16020615 1 1
2026-02-17 8-K 8-K 2.02,9.01 0001193125-26-053131 001-38443 26636581 34 406288 1 1
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000056 005-90431 26581869 34 7216
2026-01-22 4 OWNERSHIP DOCUMENT 0001104659-26-005924 8033
2026-01-22 144 xsl144X01/primary_doc.xml 0001104659-26-005919 001-38443 26552991 33 6102
2026-01-22 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-26-005917 005-90431 26552989 34 11717
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000802 005-90431 26547563 34 11423
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000657 005-90431 26545840 34 11234
2026-01-05 4 4 0001193125-26-002367 5672
2025-12-30 4 4 0001193125-25-337052 5341
2025-12-30 4 4 0001193125-25-337051 5380
2025-12-30 4 4 0001193125-25-337050 5366
2025-12-30 4 4 0001193125-25-337049 5397
2025-12-29 144 xsl144X01/primary_doc.xml 0001950047-25-010709 001-38443 251604242 33 8641
2025-12-29 144 xsl144X01/primary_doc.xml 0001950047-25-010708 001-38443 251603887 33 5712
2025-12-29 144 xsl144X01/primary_doc.xml 0001950047-25-010706 001-38443 251603866 33 5102
2025-12-29 144 xsl144X01/primary_doc.xml 0001950047-25-010704 001-38443 251603839 33 5095
2025-12-19 4 4 0001193125-25-326776 10830
2025-12-19 4 4 0001193125-25-326775 10849
2025-12-19 4 4 0001193125-25-326774 11037
2025-12-19 4 4 0001193125-25-326772 10774
2025-12-19 4 4 0001193125-25-326773 10799
2025-12-19 4 4 0001193125-25-326771 10813
2025-12-08 8-K 8-K 8.01 0001193125-25-311217 001-38443 251556134 34 168912 1 1
2025-11-18 8-K 8-K 1.01,2.03,9.01 0001193125-25-286158 001-38443 251494707 34 1201731 1 1
2025-11-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-113219 005-90431 251491508 34 21051
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000029 005-90431 251487832 34 15777
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112634 005-90431 251487304 34 12618
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-283076 005-90431 251486880 34 13169
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005033 005-90431 251486551 34 13304
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001907884-25-000004 005-90431 251483616 34 9601
2025-11-13 8-K 8-K 1.01,8.01,9.01 0001193125-25-278679 001-38443 251475196 34 674967 1 1
2025-11-12 424B5 424B5 0001193125-25-277586 333-291384 251472821 33 687607 1 1
2025-11-12 424B5 424B5 0001193125-25-277503 333-291384 251472504 33 1362209 1 1
2025-11-12 FWP FWP 0001193125-25-275686 333-291384 251468333 34 56857
2025-11-12 424B5 424B5 0001193125-25-274642 333-291384 251467599 33 546248
2025-11-12 424B5 424B5 0001193125-25-274621 333-291384 251467551 33 1209523
2025-11-10 8-K 8-K 7.01,8.01,9.01 0001193125-25-273315 001-38443 251464430 34 9060113 1 1
2025-11-07 S-3ASR S-3ASR 0001193125-25-272499 333-291384 251463278 33 1170270 1 1
2025-11-07 10-Q 10-Q 0001193125-25-272334 001-38443 251462700 34 9726974 1 1
2025-11-03 8-K 8-K 2.02,9.01 0001193125-25-261797 001-38443 251442344 34 605648 1 1
2025-10-03 4 4 0001193125-25-230215 5673
2025-09-11 8-K 8-K 1.01,2.03,9.01 0001193125-25-201353 001-38443 251308899 34 685618 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-022022 005-90431 251221523 34 22421
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000016 005-90431 251220855 34 16067
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000009 005-90431 251220801 34 12353
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078669 005-90431 251219988 34 12631
2025-08-05 10-Q 10-Q 0000950170-25-102440 001-38443 251182992 34 10408560 1 1
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-102433 001-38443 251182973 34 603974 1 1
2025-07-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-067760 005-90431 251122052 34 17398
2025-07-14 4 OWNERSHIP DOCUMENT 0001104659-25-067758 5949
2025-07-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-001001 005-90431 251117560 34 16885
2025-07-10 8-K 8-K 1.01,2.02,9.01 0001193125-25-157390 001-38443 251114855 34 424246 1 1
2025-07-09 424B5 424B5 0001193125-25-157121 333-269707 251114050 33 754576 1 1
2025-07-08 424B5 424B5 0001193125-25-156654 333-269707 251111695 33 607234
2025-07-07 8-K 8-K 8.01 0001193125-25-155811 001-38443 251106969 34 151112 1 1
2025-07-02 4 4 0000950170-25-092976 5675
2025-06-11 8-K 8-K 1.01,2.03,7.01,9.01 0001193125-25-138813 001-38443 251038824 34 165893 1 1
2025-06-05 4 4 0000950170-25-082374 5371
2025-06-05 4 4 0000950170-25-082368 5964
2025-06-05 4 4 0000950170-25-082365 5382
2025-06-05 4 4 0000950170-25-082364 5390
2025-06-05 4 4 0000950170-25-082349 5967
2025-06-05 4 4 0000950170-25-082348 5382
2025-06-05 8-K 8-K 5.03,5.07,7.01,9.01 0001193125-25-135337 001-38443 251025066 34 6326199 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049526 005-90431 25954446 34 12541
2025-05-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001478 333-264773 25932349 33 1959
2025-05-06 10-Q 10-Q 0000950170-25-064005 001-38443 25915571 34 7154965 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-063987 001-38443 25915370 34 612764 1 1
2025-05-06 424B5 424B5 0001193125-25-113402 333-269707 25915334 33 756703 1 1
2025-05-06 POS AM POS AM 0001193125-25-113367 333-264773 25915321 33 19804
2025-04-22 ARS ARS 0001193125-25-089258 001-38443 25858216 34 6375274
2025-04-22 DEFA14A DEFA14A 0001193125-25-089248 001-38443 25858178 34 143309
2025-04-22 DEF 14A DEF 14A 0001193125-25-089237 001-38443 25858127 34 2558695 1 1
2025-04-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-010591 005-90431 25833839 34 25370
2025-04-11 PRE 14A PRE 14A 0001193125-25-079139 001-38443 25832469 34 2573167 1 1
2025-04-03 4 4 0000950170-25-050374 5729
2025-02-25 S-8 S-8 0001193125-25-035115 333-285198 25662911 33 262722 1 1
2025-02-25 10-K 10-K 0000950170-25-026115 001-38443 25659567 34 22699119 1 1
2025-02-25 8-K 8-K 2.02,9.01 0000950170-25-026103 001-38443 25659519 34 647865 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001038 005-90431 25628647 34 13573
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012215 005-90431 25615399 34 16448
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000872 005-90431 25612538 34 11737
2025-01-27 4 4 0000950170-25-009271 5412
2025-01-27 4 4 0000950170-25-009266 5400
2025-01-27 4 4 0000950170-25-009263 5429
2025-01-27 4 4 0000950170-25-009258 5398
2025-01-27 4 4 0000950170-25-009257 5442
2025-01-27 4 4 0000950170-25-009256 5373
2025-01-15 4 4 0000950170-25-005630 5348
2025-01-03 4 4 0000950170-25-001210 5677
2024-12-09 8-K 8-K 8.01 0001193125-24-273393 001-38443 241535035 34 174470 1 1
2024-11-14 SC 13G/A COGENT BIOSCIENCES, INC. 0000902664-24-006674 005-90431 241465345 34 78746
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119314 005-90431 241464754 34 238752
2024-11-14 SC 13G/A formsc13ga.htm 0001493152-24-045813 005-90431 241461817 34 90499
2024-11-14 SC 13G/A d11522645_13g-a.htm 0000919574-24-006725 005-90431 241461249 34 119402
2024-11-14 SC 13G/A KYNAM CAPITAL MANAGEMENT, LP 0001085146-24-005824 005-90431 241459348 34 44401
2024-11-12 10-Q 10-Q 0000950170-24-124712 001-38443 241444004 34 6331300 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-124653 001-38443 241443724 34 422304 1 1
2024-11-07 SC 13G/A filing.txt 0000315066-24-002596 005-90431 241433521 34 8434
2024-11-07 SC 13G/A filing.txt 0000315066-24-002573 005-90431 241433471 34 8426
2024-10-02 4 4 0000950170-24-111468 5683
2024-09-03 8-K 8-K 8.01,9.01 0001193125-24-211584 001-38443 241272088 34 168020 1 1
2024-08-06 S-8 S-8 0001193125-24-194929 333-281291 241180203 33 297917 1 1
2024-08-06 10-Q 10-Q 0000950170-24-091229 001-38443 241177242 34 7099292 1 1
2024-08-06 8-K 8-K 2.02,9.01 0000950170-24-091220 001-38443 241177206 34 422278 1 1
2024-07-02 4 4 0000950170-24-080555 5682
2024-06-27 8-K 8-K 8.01,9.01 0001193125-24-169756 001-38443 241075411 34 164105 1 1
2024-06-13 4 4 0000950170-24-073238 5974
2024-06-13 4 4 0000950170-24-073235 5392
2024-06-13 4 4 0000950170-24-073234 5381
2024-06-13 4 4 0000950170-24-073231 5977
2024-06-13 4 4 0000950170-24-073228 5400
2024-06-13 4 4 0000950170-24-073226 5392
2024-06-13 SC 13D/A SC 13D/A 0001193125-24-160264 005-90431 241039944 34 53288
2024-06-12 4 4 0000950170-24-072639 9395
2024-06-05 8-K 8-K 5.03,5.07,9.01 0001193125-24-155116 001-38443 241021924 34 177528 1 1
2024-05-29 4 4 0000950170-24-065900 5537
2024-05-29 3 3 0000950170-24-065891 14357
2024-05-07 10-Q 10-Q 0000950170-24-053977 001-38443 24919748 34 6346723 1 1
2024-05-07 8-K 8-K 2.02,9.01 0000950170-24-053974 001-38443 24919737 34 382107 1 1
2024-04-23 ARS ARS 0001193125-24-107137 001-38443 24865339 34 3637548
2024-04-23 DEFA14A DEFA14A 0001193125-24-107128 001-38443 24865298 34 142689
2024-04-23 DEF 14A DEF 14A 0001193125-24-107124 001-38443 24865267 34 728179
2024-04-12 PRE 14A PRE 14A 0001193125-24-094760 001-38443 24841917 34 728636
2024-04-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-10 16:00:00 9999999995-24-000926 333-278382 24837025 33 1953
2024-04-08 CORRESP filename1.htm 0001193125-24-089670 7105
2024-04-05 UPLOAD filename1.pdf 0000000000-24-003700 333-278382 40480
2024-04-02 4 4 0000950170-24-040496 5681
2024-04-01 SC 13D/A SC 13D/A 0001193125-24-083703 005-90431 24811557 34 72840
2024-04-01 4 4 0000950170-24-039588 13115
2024-03-29 S-3 S-3 0001193125-24-082065 333-278382 24804218 33 382076
2024-03-27 SC 13D/A SC 13D/A 0001193125-24-078864 005-90431 24791393 34 73559
2024-03-22 8-K 8-K 3.02,5.03,9.01 0001193125-24-074628 001-38443 24773194 34 224854 1 1
2024-02-26 S-8 S-8 0001193125-24-046239 333-277360 24679488 33 69104
2024-02-26 10-K 10-K 0000950170-24-019770 001-38443 24673813 34 16851214 1 1
2024-02-26 8-K 8-K 2.02,9.01 0000950170-24-019754 001-38443 24673653 34 431043 1 1
2024-02-16 SC 13D/A SC 13D/A 0001193125-24-038694 005-90431 24650069 34 78497
2024-02-16 4 4 0000950170-24-016610 9962
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024207 005-90431 24641660 34 258436
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023987 005-90431 24640138 34 81662
2024-02-14 SC 13G/A COGENT BIOSCIENCES, INC. 0000902664-24-001689 005-90431 24638208 34 81898
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006621 005-90431 24637788 34 90535
2024-02-14 SC 13G KYNAM CAPITAL MANAGEMENT, LP 0001085146-24-001356 005-90431 24635189 34 44330
2024-02-14 8-K 8-K 1.01,3.02,5.03,7.01,9.01 0001193125-24-035203 001-38443 24632603 34 912862 1 1
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-020637 005-90431 24627835 34 13217
2024-02-09 SC 13G/A SC 13G/A 0001193125-24-030060 005-90431 24615335 34 57418
2024-02-09 SC 13G filing.txt 0000315066-24-001074 005-90431 24611529 34 8360
2024-02-05 SC 13G d10938931_13-g.htm 0000919574-24-000675 005-90431 24596413 34 121156
2024-01-26 SC 13G/A us19240q2012_012624.txt 0001086364-24-004363 005-90431 24565873 34 13751
2024-01-25 4 4 0000950170-24-007436 5432
2024-01-25 4 4 0000950170-24-007422 5376
2024-01-25 4 4 0000950170-24-007415 5401
2024-01-25 4 4 0000950170-24-007414 5448
2024-01-25 4 4 0000950170-24-007410 5415
2024-01-23 SC 13G/A Cogent_Bio_Inc.txt 0000093751-24-000073 005-90431 24550578 34 8655
2024-01-04 4 4 0000950170-24-001886 5681
2024-01-04 4 4 0000950170-24-001876 5692
2023-12-11 8-K 8-K 8.01 0001193125-23-292084 001-38443 231476963 34 184489 1 1
2023-11-07 10-Q 10-Q 0000950170-23-059769 001-38443 231381562 34 6877069 1 1
2023-11-02 8-K 8-K 2.02,9.01 0000950170-23-057785 001-38443 231370371 34 477007 1 1
2023-10-03 4 4 0000950170-23-051615 5612
2023-10-03 4 4 0000950170-23-051604 5598
2023-08-08 S-8 S-8 0001193125-23-206264 333-273802 231151925 33 63092
2023-08-08 10-Q 10-Q 0000950170-23-039394 001-38443 231149465 34 7091526 1 1
2023-08-08 8-K 8-K 2.02,9.01 0000950170-23-039389 001-38443 231149450 34 494027 1 1
2023-07-05 4 4 0000950170-23-031704 5598
2023-07-05 4 4 0000950170-23-031702 5609
2023-06-13 4 OWNERSHIP DOCUMENT 0001104659-23-070794 10392
2023-06-13 SC 13D/A SC 13D/A 0001104659-23-070793 005-90431 231011304 34 63459
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014905 5539
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014903 6121
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014900 5528
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014895 5547
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014890 5539
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014883 6117
2023-06-08 8-K 8-K 1.01,9.01 0001193125-23-163546 001-38443 231002356 34 416109 1 1
2023-06-08 424B5 424B5 0001193125-23-163485 333-269707 231001863 33 747245
2023-06-07 8-K 8-K 5.02,5.07,9.01 0001193125-23-162557 001-38443 23999299 34 254739 1 1
2023-06-06 424B5 424B5 0001193125-23-161747 333-269707 23997049 33 720383
2023-06-06 8-K 8-K 8.01 0001193125-23-161596 001-38443 23996056 34 157268 1 1
2023-06-01 SC 13G COGENT BIOSCIENCES, INC. 0000902664-23-003363 005-90431 23985489 34 72044
2023-05-09 10-Q 10-Q 0000950170-23-019166 001-38443 23900102 34 5691457 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019162 001-38443 23900086 34 454902 1 1
2023-04-25 ARS ARS 0001193125-23-115309 001-38443 23844969 34 13666620
2023-04-25 DEFA14A DEFA14A 0001193125-23-115292 001-38443 23844910 34 466641
2023-04-25 DEF 14A DEF 14A 0001193125-23-115281 001-38443 23844803 34 547017
2023-04-04 4 FORM 4 SUBMISSION 0000899243-23-010395 5828
2023-04-04 4 FORM 4 SUBMISSION 0000899243-23-010391 5839
2023-03-14 S-8 S-8 0001193125-23-070121 333-270522 23730672 33 83518
2023-03-14 10-K 10-K 0000950170-23-007729 001-38443 23729337 34 14921292 1 1
2023-03-14 8-K 8-K 2.02,9.01 0000950170-23-007717 001-38443 23729249 34 496657 1 1
2023-02-15 4 FORM 4 SUBMISSION 0000899243-23-005141 9590
2023-02-15 4 FORM 4 SUBMISSION 0000899243-23-005140 5466
2023-02-15 4 FORM 4 SUBMISSION 0000899243-23-005138 9554
2023-02-15 4 FORM 4 SUBMISSION 0000899243-23-005137 9567
2023-02-15 4 FORM 4 SUBMISSION 0000899243-23-005135 9607
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021868 005-90431 23631002 34 265111
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021816 005-90431 23630725 34 79029
2023-02-14 SC 13G/A formsc13ga.htm 0001493152-23-004815 005-90431 23628780 34 91594
2023-02-14 SC 13G/A AMENDMENT NO. 2 0001214659-23-002279 005-90431 23627109 34 81860
2023-02-14 SC 13G/A SC 13G/A 0001580642-23-000867 005-90431 23626684 34 58258
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038128 005-90431 23625420 34 222286
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000533 005-90431 23625113 34 277027
2023-02-10 S-3ASR S-3ASR 0001193125-23-032798 333-269707 23613090 33 540671
2023-02-10 SC 13G/A e618238_sc13ga-cbi.htm 0001193805-23-000130 005-90431 23608931 34 99723
2023-02-09 SC 13G/A JHG PLC OWNS <5% 0001274173-23-000008 005-90431 23601642 34 10245
2023-02-03 SC 13G Cogent_Biosciences_Inc.txt 0000093751-23-000162 005-90431 23585271 34 8573
2023-02-03 SC 13G us19240q2012_020323.txt 0001306550-23-007060 005-90431 23584735 34 13359
2023-01-04 4 FORM 4 SUBMISSION 0000899243-23-000619 5809
2023-01-04 4 FORM 4 SUBMISSION 0000899243-23-000615 5798
2022-12-12 8-K 8-K 7.01,9.01 0001193125-22-302302 001-38443 221456193 34 9485731 1 1
2022-11-14 10-Q 10-Q 0000950170-22-024685 001-38443 221380222 34 7911244 1 1
2022-11-14 8-K 8-K 2.02,9.01 0000950170-22-024675 001-38443 221380160 34 535487 1 1
2022-10-04 4 FORM 4 SUBMISSION 0000899243-22-032672 5842
2022-10-04 4 FORM 4 SUBMISSION 0000899243-22-032661 5831
2022-09-06 SC 13G SC 13G 0001104659-22-097869 005-90431 221228607 34 75425
2022-08-09 10-Q 10-Q 0000950170-22-015760 001-38443 221146420 34 6754864 1 1
2022-08-09 8-K 8-K 2.02,9.01 0000950170-22-015744 001-38443 221146375 34 489768 1 1
2022-07-08 SC 13G us19240q2012_070822.txt 0000834237-22-010347 005-90431 221075093 34 12497
2022-07-05 4 FORM 4 SUBMISSION 0000899243-22-024930 5831
2022-07-05 4 FORM 4 SUBMISSION 0000899243-22-024929 5842
2022-07-01 4 FORM 4 SUBMISSION 0000899243-22-024711 5023
2022-06-21 SC 13D/A SC 13D/A 0001104659-22-072800 005-90431 221026420 34 78117
2022-06-21 4 OWNERSHIP DOCUMENT 0001104659-22-072798 10335
2022-06-17 SC 13G e621751_sc13g-cbi.htm 0001193805-22-000956 005-90431 221022412 34 97452
2022-06-16 8-K/A 8-K/A 1.01,8.01,9.01 0001193125-22-175601 001-38443 221021350 34 509913 1 1
2022-06-15 8-K 8-K 1.01,9.01 0001193125-22-174885 001-38443 221018576 34 512320 1 1
2022-06-15 424B5 424B5 0001193125-22-174881 333-264773 221018556 33 578981
2022-06-14 FWP FWP 0001193125-22-173230 333-264773 221013337 34 37413
2022-06-13 424B5 424B5 0001193125-22-172369 333-264773 221010658 33 568876
2022-06-10 8-K 8-K 5.07,8.01,9.01 0001193125-22-171489 001-38443 221007623 34 10273283 1 1
2022-06-09 4 FORM 4 SUBMISSION 0000899243-22-021648 5678
2022-06-09 4 FORM 4 SUBMISSION 0000899243-22-021646 9531
2022-06-09 4 FORM 4 SUBMISSION 0000899243-22-021645 5689
2022-06-09 4 FORM 4 SUBMISSION 0000899243-22-021643 10023
2022-06-09 4 FORM 4 SUBMISSION 0000899243-22-021639 10023
2022-06-09 4 FORM 4 SUBMISSION 0000899243-22-021636 9528
2022-05-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-24 16:00:00 9999999995-22-001579 333-264773 22958810 33 1926
2022-05-20 CORRESP filename1.htm 0001193125-22-156292 6457
2022-05-17 UPLOAD filename1.pdf 0000000000-22-005363 40427
2022-05-13 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-143704,2022-05-13 9999999995-22-001452 333-252873 22925114 33 1939
2022-05-10 10-Q 10-Q 0001564590-22-019089 001-38443 22907499 34 5250104 1 1
2022-05-10 8-K 8-K 2.02,9.01 0001564590-22-019075 001-38443 22907374 34 406328 1 1
2022-05-06 S-3 S-3 0001193125-22-143829 333-264773 22902489 33 853045
2022-05-06 POS AM POS AM 0001193125-22-143704 333-252873 22901776 33 20392
2022-05-06 8-K 8-K 1.02 0001193125-22-143689 001-38443 22901482 34 149172 1 1
2022-04-26 DEFA14A DEFA14A 0001193125-22-118978 001-38443 22851880 34 680223
2022-04-26 DEF 14A DEF 14A 0001193125-22-118969 001-38443 22851874 34 805929
2022-04-05 4 FORM 4 SUBMISSION 0000899243-22-013710 9805
2022-04-05 4 FORM 4 SUBMISSION 0000899243-22-013702 9816
2022-03-17 S-8 S-8 0001193125-22-078297 333-263638 22748530 33 92596
2022-03-15 10-K 10-K 0001564590-22-010238 001-38443 22739258 34 10709128 1 1
2022-03-15 8-K 8-K 2.02,9.01 0001564590-22-010231 001-38443 22739175 34 486557 1 1
2022-03-01 SC 13G SC 13G 0001193125-22-061021 005-90431 22696933 34 152981
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022823 005-90431 22632088 34 181893
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022819 005-90431 22632072 34 82710
2022-02-14 SC 13G/A SC 13G/A 0000905718-22-000320 005-90431 22631637 34 52972
2022-02-14 SC 13G/A cogent13ga3.htm 0000935836-22-000144 005-90431 22629299 34 75148
2022-02-14 SC 13G THE SCHEDULE 13G 0000921895-22-000531 005-90431 22628945 34 289134
2022-02-14 SC 13G SC 13G 0001580642-22-000820 005-90431 22627378 34 61739
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037084 005-90431 22621228 34 123483
2022-02-11 SC 13G JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-22-000069 005-90431 22619039 34 10757
2022-02-04 SC 13G us19240q2012_020422.txt 0000834237-22-007223 005-90431 22593533 34 13381
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003475 5559
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003474 5545
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003469 5513
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003465 5576
2022-01-27 4 FORM 4 SUBMISSION 0000899243-22-003462 5590
2022-01-25 SC 13G/A SCHEDULE 13G/A 0001104659-22-007253 005-90431 22551901 34 92872
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000694 5019
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000693 5903
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000691 5914
2021-12-27 8-K 8-K 5.02,9.01 0001193125-21-367000 001-38443 211520409 34 312597 1 1
2021-11-17 SC 13G/A AMENDMENT NO. 1 0001214659-21-011957 005-90431 211420488 34 41998
2021-11-10 10-Q 10-Q 0001564590-21-055947 001-38443 211394531 34 6294884 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001564590-21-055942 001-38443 211394508 34 399368 1 1
2021-11-04 SC 13G SC 13G 0000905718-21-001428 005-90431 211376772 34 55552
2021-10-05 4 FORM 4 SUBMISSION 0000899243-21-039329 5905
2021-10-05 4 FORM 4 SUBMISSION 0000899243-21-039303 5916
2021-08-17 S-8 S-8 0001193125-21-248036 333-258865 211180213 33 52808
2021-08-16 10-Q 10-Q 0001564590-21-044445 001-38443 211174496 34 5819796 1 1
2021-08-16 8-K 8-K 2.02,9.01 0001193125-21-246896 001-38443 211174473 34 221537 1 1
2021-07-09 8-K 8-K 1.01,9.01 0001193125-21-211800 001-38443 211082860 34 405470
2021-07-08 SC 13G d78214sc13g.htm 0001214659-21-007370 005-90431 211079839 34 41854
2021-07-06 4 FORM 4 SUBMISSION 0000899243-21-027628 5916
2021-07-06 4 FORM 4 SUBMISSION 0000899243-21-027625 5905
2021-06-17 8-K 8-K 5.02,5.07,9.01 0001193125-21-192654 001-38443 211023345 34 102214
2021-05-12 10-Q 10-Q 0001564590-21-026737 001-38443 21913472 34 4669496 1
2021-05-12 8-K 8-K 2.02,9.01 0001193125-21-158322 001-38443 21913435 34 70388
2021-05-05 4 FORM 4 SUBMISSION 0000899243-21-018362 5645
2021-05-05 3 FORM 3 SUBMISSION 0000899243-21-018359 7208
2021-04-30 DEFA14A DEFA14A 0001193125-21-145002 001-38443 21877889 34 341040
2021-04-30 DEF 14A DEF 14A 0001193125-21-144950 001-38443 21877713 34 776650
2021-04-28 4 FORM 4 SUBMISSION 0000899243-21-017261 5502
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-015905 8568
2021-04-05 4 FORM 4 SUBMISSION 0000899243-21-014969 5904
2021-04-05 4 FORM 4 SUBMISSION 0000899243-21-014967 5915
2021-03-31 SEC STAFF LETTER filename1.pdf 9999999997-21-001037 273010
2021-03-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-03-18 17:00:00 9999999995-21-000998 333-252873 21756411 33 1926
2021-03-16 CORRESP filename1.htm 0001193125-21-082984 6856
2021-03-16 S-8 S-8 0001193125-21-082174 333-254320 21743678 33 72656
2021-03-16 10-K 10-K 0001564590-21-013325 001-38443 21743647 34 11382178 1
2021-03-16 8-K 8-K 2.02 0001193125-21-082091 001-38443 21743613 34 83680
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011730 9483
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011698 5451
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011695 5470
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011694 5462
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011693 9477
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011688 9479
2021-03-03 SEC STAFF LETTER filename1.pdf 9999999997-21-000710 278027
2021-03-01 4 FORM 4 SUBMISSION 0000899243-21-008812 5090
2021-02-24 4 FORM 4 SUBMISSION 0000899243-21-008077 5470
2021-02-24 3 FORM 3 SUBMISSION 0000899243-21-008076 7303
2021-02-22 8-K 8-K 5.02 0001193125-21-050875 001-38443 21661093 34 19482
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-024053 005-90431 21638807 34 79706
2021-02-16 SC 13G/A cogent13ga.htm 0000935836-21-000173 005-90431 21637011 34 78716
2021-02-12 4 FORM 4 SUBMISSION 0000899243-21-006403 5589
2021-02-12 4 FORM 4 SUBMISSION 0000899243-21-006402 7989
2021-02-12 4 FORM 4 SUBMISSION 0000899243-21-006400 5544
2021-02-12 SC 13G/A SC 13G/A 0001193125-21-041532 005-90431 21627572 34 136802
2021-02-12 UPLOAD filename1.pdf 0000000000-21-001830 40429
2021-02-12 SC 13G/A formsc13ga.htm 0001493152-21-003537 005-90431 21623606 34 185849
2021-02-11 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-21-000327 005-90431 21620510 34 283376
2021-02-09 S-3 S-3 0001193125-21-032929 333-252873 21603716 33 821304
2021-02-02 4 FORM 4 SUBMISSION 0000899243-21-004384 9779
2021-02-02 SC 13G/A SC 13G/A 0001104659-21-010771 005-90431 21580007 34 119707
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000793 9941
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000792 9940
2020-12-09 4 FORM 4 SUBMISSION 0000899243-20-033232 9760
2020-12-07 4 FORM 4 SUBMISSION 0000899243-20-032853 9215
2020-12-03 SC 13G sc13g.htm 0001493152-20-022880 005-90431 201365873 34 192927
2020-12-02 8-K 8-K 1.01,8.01,9.01 0001193125-20-308501 001-38443 201364642 34 234845
2020-12-02 424B5 424B5 0001193125-20-308495 333-230678 201364613 33 923569
2020-12-02 424B3 424B3 0001193125-20-307560 333-230678 201362205 33 51167
2020-11-30 424B5 424B5 0001193125-20-305790 333-230678 201359096 33 926497
2020-11-30 8-K 8-K 8.01,9.01 0001193125-20-305716 001-38443 201358853 34 7056939
2020-11-19 SC 13G/A cogt13ga.htm 0000935836-20-000653 005-90431 201328875 34 86074
2020-11-19 SC 13G c11182020sc13g.htm 0001214659-20-009754 005-90431 201328307 34 137294
2020-11-09 10-Q 10-Q 0001564590-20-052593 001-38443 201298714 34 7551229 1
2020-11-09 8-K 8-K 2.02,3.03,5.03,5.07,9.01 0001193125-20-288493 001-38443 201296108 34 128308
2020-11-05 S-8 S-8 0001193125-20-286975 333-249884 201291422 33 74577
2020-10-27 4 FORM 4 SUBMISSION 0001209191-20-055909 5657
2020-10-27 3 FORM 3 SUBMISSION 0001209191-20-055908 6615
2020-10-26 8-K 8-K 5.02,7.01,9.01 0001193125-20-276049 001-38443 201259019 34 187355
2020-10-23 8-K 8-K 5.02,9.01 0001193125-20-275468 001-38443 201257864 34 29278
2020-10-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-10-15 16:01:00 9999999995-20-002858 333-248971 201242685 33 1927
2020-10-15 4 FORM 4 SUBMISSION 0001209191-20-054904 5622
2020-10-13 UPLOAD filename1.pdf 0000000000-20-009654 40037
2020-10-13 CORRESP filename1.htm 0001193125-20-268507 6638
2020-10-09 DEFM14A DEFM14A 0001193125-20-267267 001-38443 201233693 34 1647071
2020-10-08 4 FORM 4 SUBMISSION 0001209191-20-054312 42689
2020-10-06 CORRESP filename1.htm 0001193125-20-264862 19221
2020-10-06 PRER14A PRER14A 0001193125-20-264858 001-38443 201227622 34 1702895
2020-10-06 10-Q/A 10-Q/A 0001193125-20-264799 001-38443 201227185 34 326881
2020-10-06 UPLOAD filename1.pdf 0000000000-20-009384 45142
2020-10-05 8-K 8-K 5.03,7.01,9.01 0001193125-20-263412 001-38443 201222446 34 8976240
2020-10-02 4 FORM 4 SUBMISSION 0001209191-20-053277 5806
2020-10-02 4 FORM 4 SUBMISSION 0001209191-20-053276 5805
2020-10-02 CORRESP filename1.htm 0001193125-20-262532 23628
2020-10-02 PRER14A PRER14A 0001193125-20-262526 001-38443 201220292 34 1859680
2020-09-30 UPLOAD filename1.pdf 0000000000-20-009214 46730
2020-09-22 S-3 S-3 0001193125-20-251424 333-248971 201190269 33 654148
2020-09-22 CORRESP filename1.htm 0001193125-20-251278 24264

Latest XBRL company facts

One latest value per concept from companyfacts (304 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 173.99M 2026-11-03 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
dei EntityPublicFloat Entity Public Float USD 772.90M 2025-06-30 2025 FY 10-K 2026-02-17 0001193125-26-053334
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 35.52 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173834
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 40.52M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173834
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 8.93M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173834
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 120.69 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173834
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 116.77M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173834
ecd PeoTotalCompAmt PeoTotalCompAmt USD 27.76M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173834
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 413.99 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173834
ffd NetFeeAmt NetFeeAmt USD 55,240 2026-08-08 424B5 2026-08-10 0001193125-26-342683
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 400.00M 2026-08-08 424B5 2026-08-10 0001193125-26-342683
ffd TtlFeeAmt TtlFeeAmt USD 55,240 2026-08-08 424B5 2026-08-10 0001193125-26-342683
ffd TtlOfferingAmt TtlOfferingAmt USD 400.00M 2026-08-08 424B5 2026-08-10 0001193125-26-342683
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-08 424B5 2026-08-10 0001193125-26-342683
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-08 424B5 2026-08-10 0001193125-26-342683
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 2.75M 2021-03-31 2021 Q1 10-Q 2021-05-12 0001564590-21-026737
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 2.00M 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 400,000 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 8.68M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -717,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.95B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 48.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 16.87M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 50.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 849,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 36.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 5,000 2017-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap Assets Assets USD 832.14M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AssetsCurrent Assets, Current USD 803.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 487,000 2020-06-30 2020 Q2 10-Q 2020-08-11 0001564590-20-039357
us-gaap AssetsFairValueDisclosureRecurring Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 28.99M 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193125-18-161541
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 363,000 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 7,000 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 588.40M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 0 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042995
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 0 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042995
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 0 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042995
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 22.92M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 588.75M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 573.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 7.46M 2023-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026115
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 81,000 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-12 0001564590-19-031485
us-gaap CapitalizedContractCostNet Capitalized Contract Cost, Net USD 0 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 217.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 217.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 18.44M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-13 0001193125-18-247281
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -94.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 3.03M 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-015760
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 173.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 173.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap CommonStockValue Common Stock, Value, Issued USD 174,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -306.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 15.20M 2019-06-30 2019 Q2 10-Q 2019-08-12 0001564590-19-031485
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.31M 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 8.71M 2017-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 7.20M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042995
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 223.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ConvertiblePreferredStockConvertedToOtherSecurities Convertible Preferred Stock Converted to Other Securities USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-053977
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 13.23M 2017-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap CostsAndExpenses Costs and Expenses USD 323.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 230.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 6.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 59.55M 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019166
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 513.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 10 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 1.37M 2017-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 748,000 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap DeferredRevenue Deferred Revenue USD 15.61M 2017-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 17.95M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 8.71M 2017-12-31 2018 Q3 10-Q 2018-11-13 0001193125-18-324954
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 5.90M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001193125-18-324954
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 3.29M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 28.90M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 100.59M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 425.00M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.43M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 70.59M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 10.88M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 3.64M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies USD 338,000 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026115
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 311.03M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage pure 0.04 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001564590-21-026737
us-gaap Depreciation Depreciation USD 2.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap DividendsCommonStock Dividends, Common Stock USD 11.45M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2018-09-30 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 104.40M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.68 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019089
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.268 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.044 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.013 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation and Amortization, Percent pure -0.123 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.061 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.009 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.079 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026115
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 15.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards Share-based Payment Arrangement, Cash Used to Settle Award USD 48.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 8.60M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2021-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044445
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 78,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -134,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -7.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 102.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 88.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -69.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 53,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -20.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 9.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -3.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -2.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 12.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -1.31M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -52,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.71M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001193125-18-324954
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 90,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 3.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 22.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap InvestmentTaxCredit Investment Tax Credit USD 200,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.80M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap LeaseCost Lease, Cost USD 221,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019089
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.083 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 30.12M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 14.10M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.95M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.39M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.31M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.23M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.15M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.51M 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024685
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 14.21M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap Liabilities Liabilities USD 315.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 832.14M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap LiabilitiesCurrent Liabilities, Current USD 73.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap LongTermDebt Long-term Debt USD 223.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 248.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 14.58M 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 44.25M 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 6.70M 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193125-18-161541
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -2,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052593
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 135.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -535,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193125-18-161541
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 15.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 5.92M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193125-18-161541
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -244.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -7.98M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193125-18-161541
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -305.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -187.93M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124712
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) USD -6.19M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetIncome New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income (Deprecated 2020-01-31) USD -6.19M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 18.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -323.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OperatingLeaseCost Operating Lease, Cost USD 3.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026115
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 15.90M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 18.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 21.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 8.54M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.88M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 689,000 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.05M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.99M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.93M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 689,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001193125-18-324954
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.88M 2019-03-31 2019 Q1 10-Q 2019-05-13 0001193125-19-144768
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 300,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.063 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -285,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-053977
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD 53,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 123,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 1.99M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026115
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -202,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 23,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap PaymentsForRestructuring Payments for Restructuring USD 4.17M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 11.60M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-053977
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 48.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 290.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 927,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 16,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 104.40M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 12.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 8.10M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026115
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 98.91M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 213.30M 2024-02-01 2024-02-29 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 2.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 306.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 320,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 15.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0000950170-25-026115
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -305.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.14M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 4.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap PurchaseObligation Purchase Obligation USD 108.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap RepaymentsOfDebt Repayments of Debt USD 54.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 221.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 44.81M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-019770
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 416,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Employee 43 2020-03-02 2021 Q1 10-Q 2021-05-12 0001564590-21-026737
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.6 2020-03-02 2021 Q1 10-Q 2021-05-12 0001564590-21-026737
us-gaap RestructuringCharges Restructuring Charges USD 4.17M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap RestructuringReserve Restructuring Reserve USD 73,000 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052593
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.49B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 7.87M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 71.30M 2018-09-30 2018 Q3 10-Q 2018-11-13 0001193125-18-324954
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 5.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 2.22M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001193125-18-161541
us-gaap SeveranceCosts1 Severance Costs USD 4.20M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013325
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 50.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 700,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.854 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.87M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.09M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.89 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 28.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 198,936 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 929,231 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 9.52 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 5.02M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.66M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.92 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 5.92 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 5.02M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.66M 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.71 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 7.54 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 12 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap SharePrice Share Price USD/shares 8.8 2020-07-06 2023 Q3 10-Q 2023-11-07 0000950170-23-059769
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 1.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 516.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.637 2018-03-16 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap StockIssued1 Stock Issued USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-019770
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 225,252 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 77.17M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.28M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 260,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-26 0000950170-24-019770
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 71.80M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5.29M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap SubleaseIncome Sublease Income USD 950,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 16,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013188
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 77.15M 2017-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 77.30M 2017-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2018-12-31 2018 FY 10-K 2019-03-28 0001193125-19-089299
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 808,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 311.03M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 92.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 10.69M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010238
us-gaap VariableLeaseCost Variable Lease, Cost USD 714,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-053334
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 168.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 45.11M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019089
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 168.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449963

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →